Pasithea Therapeutics (KTTA) Total Debt (2022 - 2023)
Pasithea Therapeutics (KTTA) has disclosed Total Debt for 2 consecutive years, with $4535.0 as the latest value for Q2 2023.
- Quarterly Total Debt changed N/A to $4535.0 in Q2 2023 from the year-ago period, while the trailing twelve-month figure was $4535.0 through Jun 2023, changed N/A year-over-year, with the annual reading at $8611.0 for FY2022, N/A changed from the prior year.
- Total Debt hit $4535.0 in Q2 2023 for Pasithea Therapeutics, down from $11481.0 in the prior quarter.
- In the past five years, Total Debt ranged from a high of $11481.0 in Q1 2023 to a low of $4535.0 in Q2 2023.